Deficiency of the complement regulator CD59a exacerbates Wallerian degeneration

Valeria Ramaglia1, Rosalind Helen Mary King, Bryan Paul Morgan

  • 1Neurogenetics Laboratory, University of Amsterdam, Amsterdam, The Netherlands.

Molecular Immunology
|February 28, 2009
PubMed

Insights

CD59a deficiency exacerbates Wallerian degeneration (WD) by increasing membrane attack complex (MAC) deposition and axonal damage after nerve injury. This highlights MAC

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • The complement system, particularly the membrane attack complex (MAC), plays a role in Wallerian degeneration (WD) after nerve injury.
  • Previous research demonstrated MAC's involvement in rapid axonal degradation and myelin clearance during WD.

Purpose of the Study:

  • To investigate the role of CD59a, a negative regulator of MAC, in the process of Wallerian degeneration.
  • To determine how CD59a deficiency impacts MAC deposition and axonal integrity during WD.

Main Methods:

  • Utilizing CD59a-deficient mice and wildtype controls following peripheral nerve injury.
  • Quantifying MAC deposition levels and residual axonal content.
  • Assessing endoneurial macrophage infiltration at the injury site.

Main Results:

  • CD59a-deficient mice exhibited higher MAC deposition compared to wildtype controls.
  • Axonal content was significantly lower in CD59a-deficient mice, indicating increased axonal damage.
  • Endoneurial macrophage numbers were elevated in CD59a-deficient mice one day post-injury.

Conclusions:

  • CD59a deficiency exacerbates Wallerian degeneration by enhancing MAC-mediated axonal damage.
  • MAC deposition is a critical determinant of axonal loss in WD.
  • These findings contribute to understanding axon loss mechanisms in nerve injury and disease.

Related Concept Videos